Related Experiment Video
Updated: Dec 12, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
Williams Turpin1, Sun-Ho Lee1, Juan Antonio Raygoza Garay1
1Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Increased intestinal permeability, a marker of gut barrier dysfunction, predicts future Crohn's disease development in asymptomatic individuals. This suggests altered gut barrier function may contribute to the disease
Area of Science:
- Gastroenterology
- Immunology
- Genetics
Background:
- Crohn's disease (CD) is linked to increased intestinal permeability, but its causal role remains unclear.
- Investigating intestinal permeability as a predictor of CD onset is crucial for understanding disease pathogenesis.
- First-degree relatives of CD patients represent a high-risk cohort for prospective studies.
Purpose of the Study:
- To prospectively determine if increased intestinal permeability predicts the future development of Crohn's disease.
- To assess the association between baseline intestinal permeability and subsequent CD diagnosis in asymptomatic individuals.
- To evaluate the utility of intestinal permeability as a biomarker for CD risk.
Main Methods:
- A prospective study of 1420 asymptomatic first-degree relatives of CD patients aged 6-35 years.
- Intestinal permeability assessed using the lactulose-to-mannitol ratio (LMR) at recruitment.
- Follow-up for CD diagnosis over a median of 7.8 years using Cox proportional hazards models.
Main Results:
- An abnormal LMR (>0.03) at baseline was significantly associated with a future CD diagnosis (HR, 3.03; P < .001).
- This association remained significant even when LMR was measured over 3 years prior to CD diagnosis (HR, 1.62; P = .029).
- 50 participants developed CD, while 1370 remained asymptomatic during the follow-up period.
Conclusions:
- Increased intestinal permeability is a significant predictor of later Crohn's disease development.
- These findings support a pathogenic model where impaired intestinal barrier function contributes to CD onset.
- Abnormal gut barrier function may serve as a valuable biomarker for identifying individuals at high risk of CD.
More Related Videos
07:32An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Renewal of Intestinal Stem Cells